BriaCell Therapeutics Corp. held its Annual General and Special Meeting of security holders on March 5, 2026. The 8-K filing reports under Item 5.07 regarding submission of matters to a vote of security holders.
Key takeaways
Annual General and Special Meeting held on March 5, 2026
Item 5.07: Submission of Matters to a Vote of Security Holders